Single-Domain Antibody-Based Protein Degrader for Synucleinopathies is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1RF1NS120488-01
Cell-Type Specific Vulnerability to Tauopathy and Its Prevention in Multiple Models
National Institutes of Health
Grant: 5R21AG059391-02
Efficacy and Mechanism of Action of Heavy-Chain α-Synuclein Antibody Fragments Derived from Llama
National Institutes of Health
Grant: 5R01AG032611-10
Clearance and In Vivo Detection of Tau Pathology
National Institutes of Health
Grant: 1R56AG083436-01
Single domain antibodies for diagnosis and treatment of synucleinopathies
National Institutes of Health
Grant: 5R01NS077239-09
Epitope-Specific Targeting of Tau Aggregates.
NIA NIH HHS
Grant: R21 AG059391
NIA NIH HHS
Grant: R56 AG083436
NINDS NIH HHS
Grant: R01 NS077239
NINDS NIH HHS
Grant: RF1 NS120488
NIA NIH HHS
Grant: R01 AG032611
Fields of Study
Keywords
Sustainable Development Goals